Clinical Laboratories: Turn a Cybersecurity Risk Into a Seamless Upgrade

October 14, 2025

Lab directors and administrators face a critical milestone: Microsoft will end support for Windows 10 on October 14, 2025. After this date, Microsoft will no longer release security updates, leaving systems open to malware and cyberattacks.¹... Read more »

Alcohol Assay from Carolina Liquid Chemistries Receives CLIA Moderate Complexity Categorization on Abbott ImmTox™ 270 Chemistry Analyzer

August 14, 2025

GREENSBORO, NC — (August 14, 2025) — An ethyl alcohol (ETOH) assay from Carolina Liquid Chemistries Corp. (CLC) has been categorized as moderately complex under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for use... Read more »

Medline to Offer First Ever FDA-Cleared, Point-of-Care Fentanyl Urine Screening Kit on RYAN™ Analyzer

August 2, 2024

GREENSBORO, NC — (July 31, 2024) — Carolina Liquid Chemistries Corp. (CLC) has entered into a distribution agreement with Medline Industries, LP (Medline) to make the first ever FDA-cleared, point-of-care fentanyl screening test kit readily... Read more »

Carolina Liquid Chemistries Now Offers K-ASSAY® CLIA Moderate Complexity Microalbumin Reagent for Use on the Medica EasyRA® Benchtop Clinical Chemistry Analyzer

November 30, 2023

GREENSBORO, NC — (November 30, 2023) – Carolina Liquid Chemistries Corp. (CLC) has partnered with Kamiya Biomedical Company (Kamiya) to obtain CLIA1 moderate complexity categorization for K-ASSAY® Microalbumin reagent for use on the Medica EasyRA®... Read more »

Drug Screening Assays Now Available on the Diazyme DZ-Lite™ c270 Benchtop Clinical Chemistry Analyzer

September 6, 2023

Making It One of the Most Versatile Analyzers on the Market with an Extensive Test Menu Including General Chemistries, Special Chemistries, and Drug Tests GREENSBORO, NC — (September 6, 2023) – Carolina Liquid Chemistries Corp.... Read more »

First Ever Point-of-Care Instrument to Test for Fentanyl Receives FDA Clearance

March 8, 2023

Greensboro, NC (March 8, 2023) – Shenzhen Superbio Technology Co., LTD. (Superbio) has received clearance from the US Food and Drug Administration (FDA) on the first ever point-of-care instrument intended for qualitative detection of fentanyl in... Read more »

Carolina Liquid Chemistries Corp. and Diazyme Laboratories, Inc. Announce Partnership Expanding Test Menu on the Diazyme DZ-Lite™ c270 Benchtop Clinical Chemistry Analyzer, Adding 25 New Assays Totaling Over 45 CLIA Categorized Assays

January 20, 2023

GREENSBORO, NC — (Jan. 20, 2023) – Carolina Liquid Chemistries Corp. (CLC) and Diazyme Laboratories, Inc. (Diazyme) announce a partnership to expand the test menu on the Diazyme DZ-Lite™ c270 benchtop clinical chemistry analyzer. Diazyme,... Read more »

Carolina Liquid Chemistries Corp. Partners with Alltests Clinical Solutions, LLC to Distribute ACON Laboratories Flowflex™ COVID-19 Antigen Home Test

December 23, 2021

Greensboro, NC (December 22, 2021) – Veteran owned Carolina Liquid Chemistries Corp. (CLC) announced it has teamed up with New Jersey-based Alltests Clinical Solutions, LLC (Alltests), an authorized distributor, to distribute the Flowflex COVID-19 Antigen... Read more »

First Point-of-Care (POC) COVID-19 Antibody Test Now Available from Carolina Liquid Chemistries

October 5, 2020

FDA Emergency Use Authorization Reissued to Allow Fingerstick Blood Samples GREENSBORO, NC — (September 30, 2020) — The US Food and Drug Administration (FDA) announced that it has authorized the first antibody test intended for... Read more »

COVID-19 Test Kits Offered by Carolina Liquid Chemistries Granted FDA Emergency Use Authorization

July 28, 2020

Diagnostics Company Partners with Manufacturers to Bring Desperately Needed Molecular and Antibody Test Kits and Supplies to Market During the Pandemic GREENSBORO, NC — (July 28, 2020) — Carolina Liquid Chemistries, Corp. (CLC), an innovative... Read more »

« Older Entries